“AI explodes: Taking the Pulse of artificial intelligence in medicine,” is the title of the latest issue of the Stanford Medicine Magazine. The issue includes a number of articles that explore the promise of AI in medicine, ranging from What’s driving this tumor, — which discusses the efforts to stymie breast cancer through gene testing and AI, — to Adding ethics to the mix when developing health care AI, — which deals with the potential hazards posed by algorithms developed by AI experts with no formal training in the ethical standards for treating patients.
“Imagine a future where your doctor has an AI medical assistant by their side – distilling, in seconds, a world’s worth of medical research into a personalized treatment plan for you,” wrote Dr. Lloyd Minor, Dean of the Stanford University School of Medicine in the issue’s Letter from the Dean. “What if, at the click of a button, a researcher could design a custom molecule with the potential to treat a previously untreatable disease? With artificial intelligence’s rapid emergence, we are barreling toward this reality. Academic medical centers around the world, including Stanford Medicine, have begun investigating how AI, including large language models such as ChatGPT, can help us improve patient care, reduce clinician workload, better understand complex biological systems and accelerate drug discovery.”
As I discussed in a recent blog, “The Promise of Generative AI in Healthcare,” there’s a lot of excitement that AI might help us address our highly complex healthcare industry. Healthcare is a system of coupled systems, encompassing medical and pharmaceutical research; the delivery of healthcare to patients by a variety of practitioners, including hospitals, physicians, nurses, and pharmacists; and the insurance companies and governments that pay for healthcare.
According to Wikipedia, the healthcare industry comprises over 10% of the GDP of most developed countries. “The per capita expenditure on health and pharmaceuticals in OECD countries has steadily grown from a couple of hundred in the 1970s to an average of US$4'000 per year in current purchasing power parities.” In 2022, US healthcare spending “grew 4.1% to $4.5 trillion in 2022, or $13,493 per person, and accounted for 17.3% of Gross Domestic Product (GDP).”
In addition to its inherent complexity, healthcare has several attributes that make the successful deployment of new technologies significantly more challenging than in other industries. HIPPA, for example, protects the privacy of individuals in the US, but it also restricts the data sharing that’s essential to achieving many of the benefits of generative AI. And because the stakes in healthcare are too high to tolerate flaws that could harm patients, it’s harder to introduce new technologies and applications compared to most other industries.